| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63629-8722-1 | 63629-8722 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20210819 | N/A | ANDA | ANDA076732 | Bryant Ranch Prepack | METOLAZONE | 2.5 mg/1 | 100 TABLET in 1 BOTTLE (63629-8722-1) |
| 71610-285-09 | 71610-285 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20190531 | N/A | ANDA | ANDA076732 | Aphena Pharma Solutions - Tennessee, LLC | METOLAZONE | 2.5 mg/1 | 9000 TABLET in 1 BOTTLE (71610-285-09) |
| 0185-5050-01 | 0185-5050 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20031219 | N/A | ANDA | ANDA076732 | Sandoz Inc | METOLAZONE | 2.5 mg/1 | 100 TABLET in 1 BOTTLE (0185-5050-01) |
| 0185-5050-10 | 0185-5050 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20031219 | N/A | ANDA | ANDA076732 | Sandoz Inc | METOLAZONE | 2.5 mg/1 | 1000 TABLET in 1 BOTTLE (0185-5050-10) |